Skip to main content
Top
Published in: Heart and Vessels 3/2024

Open Access 13-11-2023 | Acute Kidney Injury | Original Article

Biomarker array for prediction of acute kidney injury after percutaneous coronary intervention for patients who had acute ST segment elevation myocardial infarction

Authors: Amr Alkassas, Yasser Elbarbary, Mohammed H. Sherif, Shaimaa B. El-Saied, Rasha Y. Hagag, Mohammed Elbarbary

Published in: Heart and Vessels | Issue 3/2024

Login to get access

Abstract

Acute kidney injury (AKI) is a common complication after Percutaneous Coronary Intervention (PCI) for ST segment elevation myocardial infarction (STEMI) and is associated with poor outcomes. AKI is diagnosed by the dynamic change of serum Cr, but it could not predict AKI. This study aimed to evaluate a biomarker array that may fulfill this shortage. Setting: Cardiology Department, Tanta University Hospital. Design: Prospective interventional study included 280 acute STEMI patients who underwent emergency PCI. Serial samples of blood and urine were obtained at the time of admission to the hospital (T0) and PCI unit (T1) and at 12 h and 72 h (T12 and T72) after coronary revascularization to estimate levels of serum Cr, creatine phosphokinase, and heart-type fatty acid-binding protein (H-FABP) and calculation of neutrophil/lymphocyte ratio (NLR) and urinary liver-type FABP (L-FABP). AKI was diagnosed according to the recommendations of the European Renal Best Practice as the times of increased serum Cr concerning baseline level. 85 patients developed AKI. Regression analyses defined a high NLR ratio in the T0 sample as the most significant predictor for early AKI diagnosed at T1 time, while high NLR and serum H-FABP levels in T1 samples as the significant predictors for AKI defined at T12 time. However, high urinary L-FABP levels in T12 samples and high NLR are significant predictors for AKI at T72 time. Combined estimations of serum H-FABP and urinary L-FABP with the calculation of NLR could predict the oncoming AKI and discriminate its pathogenesis. The study protocol was approved by the Local Ethical Committee at Tanta Faculty of Medicine by approval number: 35327/3/22. For blindness purposes, the authors will be blinded about the laboratory results till the end of 72 h after revascularization and the clinical pathologist will be blinded about the indication for the requested investigations.
Literature
1.
go back to reference Kumar H, Jilanee D, Mehta SM, Gul A, Shah SMH, Saleem S, Sarfraz MB, Ashraf SU, Wali S (2022) Frequency and predictors of acute kidney injury in patients with acute coronary syndrome in a tertiary care hospital: a retrospective study. Cureus 14(2):e21869PubMedPubMedCentral Kumar H, Jilanee D, Mehta SM, Gul A, Shah SMH, Saleem S, Sarfraz MB, Ashraf SU, Wali S (2022) Frequency and predictors of acute kidney injury in patients with acute coronary syndrome in a tertiary care hospital: a retrospective study. Cureus 14(2):e21869PubMedPubMedCentral
2.
go back to reference Schmucker J, Fach A, Becker M, Seide S, Bünger S, Zabrocki R, Fiehn E, Würmann-Busch B, Pohlabeln H, Günther K, Ahrens W, Hambrecht R, Wienbergen H (2018) Predictors of acute kidney injury in patients admitted with ST-elevation myocardial infarction-results from the Bremen STEMI-Registry. Eur Heart J Acute Cardiovasc Care 7:710–722PubMedCrossRef Schmucker J, Fach A, Becker M, Seide S, Bünger S, Zabrocki R, Fiehn E, Würmann-Busch B, Pohlabeln H, Günther K, Ahrens W, Hambrecht R, Wienbergen H (2018) Predictors of acute kidney injury in patients admitted with ST-elevation myocardial infarction-results from the Bremen STEMI-Registry. Eur Heart J Acute Cardiovasc Care 7:710–722PubMedCrossRef
3.
go back to reference Cosentino N, Resta M, Somaschini A, Campodonico J, Lucci C, Moltrasio M, Bonomi A, Cornara S, Camporotondo R, Demarchi A, De Ferrari G, Bartorelli A, Marenzi G (2021) Acute kidney injury and in-hospital mortality in patients with ST-elevation myocardial infarction of different age groups. Int J Cardiol 344:8–12PubMedCrossRef Cosentino N, Resta M, Somaschini A, Campodonico J, Lucci C, Moltrasio M, Bonomi A, Cornara S, Camporotondo R, Demarchi A, De Ferrari G, Bartorelli A, Marenzi G (2021) Acute kidney injury and in-hospital mortality in patients with ST-elevation myocardial infarction of different age groups. Int J Cardiol 344:8–12PubMedCrossRef
4.
go back to reference Butt K, D’Souza J, Yuan C, Jayakumaran J, Nguyen M, Butt H, Abusaada K (2020) Correlation of the neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) with contrast-induced nephropathy in patients with acute coronary syndrome undergoing percutaneous coronary interventions. Cureus 12(12):e11879PubMedPubMedCentral Butt K, D’Souza J, Yuan C, Jayakumaran J, Nguyen M, Butt H, Abusaada K (2020) Correlation of the neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) with contrast-induced nephropathy in patients with acute coronary syndrome undergoing percutaneous coronary interventions. Cureus 12(12):e11879PubMedPubMedCentral
5.
go back to reference Abdalla M, Ahmed K, Yousef B (2022) Incidence and risk factors of contrast-induced acute kidney injury in sudanese patients undergoing coronary angiography: a descriptive prospective study. Cureus 14(2):e21876PubMedPubMedCentral Abdalla M, Ahmed K, Yousef B (2022) Incidence and risk factors of contrast-induced acute kidney injury in sudanese patients undergoing coronary angiography: a descriptive prospective study. Cureus 14(2):e21876PubMedPubMedCentral
6.
go back to reference Uzunhasan I, Yildiz A, Arslan S, Abaci O, Kocas C, Kocas B, Cetinkal G, Dalgic Y, Karaca O, Dogan S (2017) Contrast-induced acute kidney injury is associated with long-term adverse events in patients with acute coronary syndrome. Angiology 68(7):621–626PubMedCrossRef Uzunhasan I, Yildiz A, Arslan S, Abaci O, Kocas C, Kocas B, Cetinkal G, Dalgic Y, Karaca O, Dogan S (2017) Contrast-induced acute kidney injury is associated with long-term adverse events in patients with acute coronary syndrome. Angiology 68(7):621–626PubMedCrossRef
7.
go back to reference Natha J, Javaheri P, Kruger D, Benterud E, Pearson W, Tan Z, Ma B, Tyrrell B, Har B, Graham M, James M (2020) Patient experience after risk stratification and follow-up for acute kidney injury after cardiac catheterization: patient survey. CJC Open 3(3):337–344PubMedPubMedCentralCrossRef Natha J, Javaheri P, Kruger D, Benterud E, Pearson W, Tan Z, Ma B, Tyrrell B, Har B, Graham M, James M (2020) Patient experience after risk stratification and follow-up for acute kidney injury after cardiac catheterization: patient survey. CJC Open 3(3):337–344PubMedPubMedCentralCrossRef
8.
go back to reference Vera M, Koch C, Kavsak P, El-Khoury J (2021) Determination of 97.5th and 99th percentile upper reference limits for heart-type fatty acid-binding protein (H-FABP) in a US population. Clin Chim Acta 523:397–401PubMedCrossRef Vera M, Koch C, Kavsak P, El-Khoury J (2021) Determination of 97.5th and 99th percentile upper reference limits for heart-type fatty acid-binding protein (H-FABP) in a US population. Clin Chim Acta 523:397–401PubMedCrossRef
9.
go back to reference Al-Hadi H, William B, Fox K (2009) Serum level of heart-type fatty acid-binding protein in patients with chronic renal failure. Sultan Qaboos Univ Med J 9(3):311–314PubMedPubMedCentral Al-Hadi H, William B, Fox K (2009) Serum level of heart-type fatty acid-binding protein in patients with chronic renal failure. Sultan Qaboos Univ Med J 9(3):311–314PubMedPubMedCentral
10.
go back to reference Moon MG, Yoon CH, Lee K, Kang SH, Youn TJ, Chae IH (2021) Evaluation of heart-type fatty acid-binding protein in early diagnosis of acute myocardial infarction. J Korean Med Sci 36(8):e61PubMedPubMedCentralCrossRef Moon MG, Yoon CH, Lee K, Kang SH, Youn TJ, Chae IH (2021) Evaluation of heart-type fatty acid-binding protein in early diagnosis of acute myocardial infarction. J Korean Med Sci 36(8):e61PubMedPubMedCentralCrossRef
11.
go back to reference Kamijo-Ikemori A, Ichikawa D, Matsui K, Yokoyama T, Sugaya T, Kimura K (2013) Urinary L-type fatty acid-binding protein (L-FABP) as a new urinary biomarker promulgated by the Ministry of Health, Labour and Welfare in Japan. Rinsho Byori 61(7):635–640PubMed Kamijo-Ikemori A, Ichikawa D, Matsui K, Yokoyama T, Sugaya T, Kimura K (2013) Urinary L-type fatty acid-binding protein (L-FABP) as a new urinary biomarker promulgated by the Ministry of Health, Labour and Welfare in Japan. Rinsho Byori 61(7):635–640PubMed
12.
go back to reference Sunayama T, Yatsu S, Matsue Y, Dotare T, Maeda D, Ishiwata S, Nakamura Y, Suda S, Kato T, Hiki M, Kasai T, Minamino T (2022) Urinary liver-type fatty acid-binding protein as a prognostic marker in patients with acute heart failure. ESC Heart Fail 9(1):442–449PubMedCrossRef Sunayama T, Yatsu S, Matsue Y, Dotare T, Maeda D, Ishiwata S, Nakamura Y, Suda S, Kato T, Hiki M, Kasai T, Minamino T (2022) Urinary liver-type fatty acid-binding protein as a prognostic marker in patients with acute heart failure. ESC Heart Fail 9(1):442–449PubMedCrossRef
13.
go back to reference Ibanez B, James S, Agewall S, Antunes M, Bucciarelli-Ducci C, Bueno H, Caforio A, Crea F, Goudevenos J, Halvorsen S, Hindricks G, Kastrati A, Lenzen M, Prescott E, Roffi M, Valgimigli M, Varenhorst C, Vranckx P, Widimský P, ESC Scientific Document Group (2018) 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 39(2):119–177PubMedCrossRef Ibanez B, James S, Agewall S, Antunes M, Bucciarelli-Ducci C, Bueno H, Caforio A, Crea F, Goudevenos J, Halvorsen S, Hindricks G, Kastrati A, Lenzen M, Prescott E, Roffi M, Valgimigli M, Varenhorst C, Vranckx P, Widimský P, ESC Scientific Document Group (2018) 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 39(2):119–177PubMedCrossRef
14.
go back to reference Levey A, Stevens L, Schmid C, Zhang Y, Castro A, Feldman H, Kusek J, Eggers P, Van Lente F, Greene T, Coresh J (2009) CKD-EPI (Chronic kidney disease epidemiology collaboration): a new equation to estimate glomerular filtration rate. Ann Intern Med 150(9):604–612PubMedPubMedCentralCrossRef Levey A, Stevens L, Schmid C, Zhang Y, Castro A, Feldman H, Kusek J, Eggers P, Van Lente F, Greene T, Coresh J (2009) CKD-EPI (Chronic kidney disease epidemiology collaboration): a new equation to estimate glomerular filtration rate. Ann Intern Med 150(9):604–612PubMedPubMedCentralCrossRef
15.
go back to reference Ad-Hoc Working Group of ERBP, Fliser D, Laville M, Covic A, Fouque D, Vanholder R, Juillard L, Van Biesen W (2012) A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) clinical practice guidelines on acute kidney injury: part 1: definitions, conservative management, and contrast-induced nephropathy. Nephrol Dial Transplant 27(12):4263–4272CrossRef Ad-Hoc Working Group of ERBP, Fliser D, Laville M, Covic A, Fouque D, Vanholder R, Juillard L, Van Biesen W (2012) A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) clinical practice guidelines on acute kidney injury: part 1: definitions, conservative management, and contrast-induced nephropathy. Nephrol Dial Transplant 27(12):4263–4272CrossRef
16.
go back to reference Khot U, Jia G, Moliterno D, Lincoff M, Khot M, Harrington R, Topol E (2003) Prognostic importance of physical examination for heart failure in non-ST-elevation acute coronary syndromes the enduring value of killip classification. JAMA 290(16):2174–2181PubMedCrossRef Khot U, Jia G, Moliterno D, Lincoff M, Khot M, Harrington R, Topol E (2003) Prognostic importance of physical examination for heart failure in non-ST-elevation acute coronary syndromes the enduring value of killip classification. JAMA 290(16):2174–2181PubMedCrossRef
17.
go back to reference Tinder P (1969) Determination of blood glucose. Ann Clin Biochem 6:24 Tinder P (1969) Determination of blood glucose. Ann Clin Biochem 6:24
18.
go back to reference Aminlari M, Vaseghi T (1987) A new colorimetric method for determination of creatine phosphokinase. Anal Biochem 164(2):397–404PubMedCrossRef Aminlari M, Vaseghi T (1987) A new colorimetric method for determination of creatine phosphokinase. Anal Biochem 164(2):397–404PubMedCrossRef
19.
go back to reference Jaffe M (1886) Ueber den Niederschlag, welchen Pikrinsäure in normalem Harn erzeugt und über eine neue Reaction des Kreatinins. ZPhysiolChem 10:391–400 Jaffe M (1886) Ueber den Niederschlag, welchen Pikrinsäure in normalem Harn erzeugt und über eine neue Reaction des Kreatinins. ZPhysiolChem 10:391–400
20.
go back to reference Peake M, Whiting M (2006) Measurement of serum creatinine–current status and future goals. Clin Biochem Rev 27:173–184PubMedPubMedCentral Peake M, Whiting M (2006) Measurement of serum creatinine–current status and future goals. Clin Biochem Rev 27:173–184PubMedPubMedCentral
21.
go back to reference Liu Y, Tian M, Jiang X, Luo J, Yi Z (2014) Evaluation of a heart-type fatty acid-binding protein detection kit for diagnosis of the acute coronary syndrome. Nan Fang Yi Ke Da Xue Xue Bao 34(6):901–903PubMed Liu Y, Tian M, Jiang X, Luo J, Yi Z (2014) Evaluation of a heart-type fatty acid-binding protein detection kit for diagnosis of the acute coronary syndrome. Nan Fang Yi Ke Da Xue Xue Bao 34(6):901–903PubMed
22.
go back to reference Taussky HH (1961) Creatinine and creatine in urine and serum. In: Seligson D (ed) Standard methods of clinical chemistry, vol 3. Academic Press, New York, pp 99–113 Taussky HH (1961) Creatinine and creatine in urine and serum. In: Seligson D (ed) Standard methods of clinical chemistry, vol 3. Academic Press, New York, pp 99–113
23.
go back to reference Faul F, Erdfelder E, Lang AG, Buchner A (2007) G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 39:175–191PubMedCrossRef Faul F, Erdfelder E, Lang AG, Buchner A (2007) G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 39:175–191PubMedCrossRef
24.
go back to reference Prowle J, Calzavacca P, Licari E, Ligabo V, Echeverri J, Bagshaw S, Haase-Fielitz A, Haase M, Ostland V, Noiri E, Westerman M, Devarajan P, Bellomo R (2015) Combination of biomarkers for diagnosis of acute kidney injury after cardiopulmonary bypass. Ren Fail 37(3):408–416PubMedCrossRef Prowle J, Calzavacca P, Licari E, Ligabo V, Echeverri J, Bagshaw S, Haase-Fielitz A, Haase M, Ostland V, Noiri E, Westerman M, Devarajan P, Bellomo R (2015) Combination of biomarkers for diagnosis of acute kidney injury after cardiopulmonary bypass. Ren Fail 37(3):408–416PubMedCrossRef
25.
go back to reference Deftereos S, Giannopoulos G, Tzalamouras V, Raisakis K, Kossyvakis C, Kaoukis A, Panagopoulou V, Karageorgiou S, Avramides D, Toutouzas K, Hahalis G, Pyrgakis V, Manolis A, Alexopoulos D, Stefanadis C, Cleman M (2013) Renoprotective effect of remote ischemic post-conditioning by intermittent balloon inflations in patients undergoing percutaneous coronary intervention. J Am Coll Cardiol 61:1949–1955PubMedCrossRef Deftereos S, Giannopoulos G, Tzalamouras V, Raisakis K, Kossyvakis C, Kaoukis A, Panagopoulou V, Karageorgiou S, Avramides D, Toutouzas K, Hahalis G, Pyrgakis V, Manolis A, Alexopoulos D, Stefanadis C, Cleman M (2013) Renoprotective effect of remote ischemic post-conditioning by intermittent balloon inflations in patients undergoing percutaneous coronary intervention. J Am Coll Cardiol 61:1949–1955PubMedCrossRef
26.
go back to reference Yamanaka T, Kawai Y, Miyoshi T, Mima T, Takagaki K, Tsukuda S, Kazatani Y, Nakamura K, Ito H (2015) Remote ischemic preconditioning reduces contrast-induced acute kidney injury in patients with ST elevation myocardial infarction: a randomized controlled trial. Int J Cardiol 178:136–141PubMedCrossRef Yamanaka T, Kawai Y, Miyoshi T, Mima T, Takagaki K, Tsukuda S, Kazatani Y, Nakamura K, Ito H (2015) Remote ischemic preconditioning reduces contrast-induced acute kidney injury in patients with ST elevation myocardial infarction: a randomized controlled trial. Int J Cardiol 178:136–141PubMedCrossRef
27.
go back to reference Tai H, Jiang X, Lan Z, Li Y, Kong L, Yao S, Song N, Lv M, Wu J, Yang P, Xiao X, Yang G, Kuang J, Jia L (2021) Tanshinone IIA combined with CsA inhibit myocardial cell apoptosis induced by renal ischemia–reperfusion injury in obese rats. BMC Complement Med Ther 21:100PubMedPubMedCentralCrossRef Tai H, Jiang X, Lan Z, Li Y, Kong L, Yao S, Song N, Lv M, Wu J, Yang P, Xiao X, Yang G, Kuang J, Jia L (2021) Tanshinone IIA combined with CsA inhibit myocardial cell apoptosis induced by renal ischemia–reperfusion injury in obese rats. BMC Complement Med Ther 21:100PubMedPubMedCentralCrossRef
28.
go back to reference Li Y, Shi D, Zhang H, Yao X, Ren K (2022) Magnetic resonance imaging of contrast-induced acute renal injury and related pathological alterations in vivo. Anal Cell Pathol (Amst) 2022:6984200PubMed Li Y, Shi D, Zhang H, Yao X, Ren K (2022) Magnetic resonance imaging of contrast-induced acute renal injury and related pathological alterations in vivo. Anal Cell Pathol (Amst) 2022:6984200PubMed
29.
go back to reference Horikawa T, Maehata J, Hashimoto F, Ikuhara T, Araki H, Umeno H, Sano Y, Ishikawa C, Takagi H, Watanabe A, Koizumi T (2022) Constructing a continuous hemodiafiltration-type circulatory model of acute kidney injury in pigs. Ther Apher Dial 26:507–514PubMedPubMedCentralCrossRef Horikawa T, Maehata J, Hashimoto F, Ikuhara T, Araki H, Umeno H, Sano Y, Ishikawa C, Takagi H, Watanabe A, Koizumi T (2022) Constructing a continuous hemodiafiltration-type circulatory model of acute kidney injury in pigs. Ther Apher Dial 26:507–514PubMedPubMedCentralCrossRef
30.
go back to reference Shacham Y, Gal-Oz A, Flint N, Keren G, Arbel Y (2016) Serum uric acid levels and renal impairment among ST-segment elevation myocardial infarction patients undergoing primary percutaneous intervention. Cardiorenal Med 6:191–197PubMedPubMedCentralCrossRef Shacham Y, Gal-Oz A, Flint N, Keren G, Arbel Y (2016) Serum uric acid levels and renal impairment among ST-segment elevation myocardial infarction patients undergoing primary percutaneous intervention. Cardiorenal Med 6:191–197PubMedPubMedCentralCrossRef
31.
go back to reference Taduru SS, Ramakrishnan M, Mustafa RA, Baweja PS (2017) Comparison of the frequency of acute kidney injury in patients with renal transplant who underwent percutaneous coronary intervention versus coronary artery bypass graft surgery. Am J Cardiol 120:1104–1109PubMedCrossRef Taduru SS, Ramakrishnan M, Mustafa RA, Baweja PS (2017) Comparison of the frequency of acute kidney injury in patients with renal transplant who underwent percutaneous coronary intervention versus coronary artery bypass graft surgery. Am J Cardiol 120:1104–1109PubMedCrossRef
32.
go back to reference Mezhonov EM, Vyalkina YA, Vakulchik KA, Halaev SVS (2018) Contrast-induced acute renal injury after percutaneous coronary interventioni in patients with ST-segment elevation myocardial infarction. Kardiologiia 8:5–11CrossRef Mezhonov EM, Vyalkina YA, Vakulchik KA, Halaev SVS (2018) Contrast-induced acute renal injury after percutaneous coronary interventioni in patients with ST-segment elevation myocardial infarction. Kardiologiia 8:5–11CrossRef
33.
go back to reference Shirakabe A, Hata N, Kobayashi N, Okazaki H, Shinada T, Tomita K, Yamamoto M, Tsurumi M, Matsushita M, Yamamoto Y, Yokoyama S, Asai K, Shimizu W (2015) Serum heart-type fatty acid-binding protein level can be used to detect acute kidney injury on admission and predict an adverse outcome in patients with acute heart failure. Circ J 79:119–128PubMedCrossRef Shirakabe A, Hata N, Kobayashi N, Okazaki H, Shinada T, Tomita K, Yamamoto M, Tsurumi M, Matsushita M, Yamamoto Y, Yokoyama S, Asai K, Shimizu W (2015) Serum heart-type fatty acid-binding protein level can be used to detect acute kidney injury on admission and predict an adverse outcome in patients with acute heart failure. Circ J 79:119–128PubMedCrossRef
34.
go back to reference Shirakabe A, Hata N, Kobayashi N, Okazaki H, Matsushita M, Shibata Y, Uchiyama S, Sawatani T, Asai K, Shimizu W (2019) Worsening renal failure in patients with acute heart failure: the importance of cardiac biomarkers. ESC Heart Fail 6:416–427PubMedPubMedCentralCrossRef Shirakabe A, Hata N, Kobayashi N, Okazaki H, Matsushita M, Shibata Y, Uchiyama S, Sawatani T, Asai K, Shimizu W (2019) Worsening renal failure in patients with acute heart failure: the importance of cardiac biomarkers. ESC Heart Fail 6:416–427PubMedPubMedCentralCrossRef
35.
go back to reference Haybar H, Assareh A, Mohammadzadeh M, Hovyzian S (2020) Relationship between level of heart type fatty acid binding protein (before and after procedures) with acute renal failure after PCI in patients under PCI. Cardiovasc Hematol Disord Drug Targets 20:41–46PubMedCrossRef Haybar H, Assareh A, Mohammadzadeh M, Hovyzian S (2020) Relationship between level of heart type fatty acid binding protein (before and after procedures) with acute renal failure after PCI in patients under PCI. Cardiovasc Hematol Disord Drug Targets 20:41–46PubMedCrossRef
36.
go back to reference Yamamoto T, Noiri E, Ono Y, Doi K, Negishi K, Kamijo A, Kimura K, Fujita T, Kinukawa T, Taniguchi H, Nakamura K, Goto M, Shinozaki N, Ohshima S, Sugaya T (2007) Renal L-type fatty acid-binding protein in acute ischemic injury. J Am Soc Nephrol 18:2894–2902PubMedCrossRef Yamamoto T, Noiri E, Ono Y, Doi K, Negishi K, Kamijo A, Kimura K, Fujita T, Kinukawa T, Taniguchi H, Nakamura K, Goto M, Shinozaki N, Ohshima S, Sugaya T (2007) Renal L-type fatty acid-binding protein in acute ischemic injury. J Am Soc Nephrol 18:2894–2902PubMedCrossRef
37.
go back to reference Hwang Y, Hyun M, Choi B, Chun S, Cho M (2014) Acute kidney injury after using contrast during cardiac catheterization in children with heart disease. J Korean Med Sci 29:1102–1107PubMedPubMedCentralCrossRef Hwang Y, Hyun M, Choi B, Chun S, Cho M (2014) Acute kidney injury after using contrast during cardiac catheterization in children with heart disease. J Korean Med Sci 29:1102–1107PubMedPubMedCentralCrossRef
38.
go back to reference Naruse H, Ishii J, Takahashi H, Kitagawa F, Nishimura H, Kawai H, Muramatsu T, Harada M, Yamada A, Motoyama S, Matsui S, Hayashi M, Sarai M, Watanabe E, Izawa H, Ozaki Y (2018) Predicting acute kidney injury using urinary liver-type fatty-acid binding protein and serum N-terminal pro-B-type natriuretic peptide levels in patients treated at medical cardiac intensive care units. Crit Care 22:197PubMedPubMedCentralCrossRef Naruse H, Ishii J, Takahashi H, Kitagawa F, Nishimura H, Kawai H, Muramatsu T, Harada M, Yamada A, Motoyama S, Matsui S, Hayashi M, Sarai M, Watanabe E, Izawa H, Ozaki Y (2018) Predicting acute kidney injury using urinary liver-type fatty-acid binding protein and serum N-terminal pro-B-type natriuretic peptide levels in patients treated at medical cardiac intensive care units. Crit Care 22:197PubMedPubMedCentralCrossRef
39.
go back to reference Yoshihara F, Hosoda H, Doi T, Yoshida M, Kitamura K, Yamamoto H, Asaumi Y, Ishibashi-Ueda H, Kishida M, Arisato T, Matsuo M, Miyazato M, Yasuda S (2021) Combined evaluation of plasma B-type natriuretic peptide and urinary liver-type fatty acid-binding protein/creatinine ratio is related to worsening renal function in patients undergoing elective percutaneous coronary intervention. Clin Exp Nephrol 25:1319–1328PubMedCrossRef Yoshihara F, Hosoda H, Doi T, Yoshida M, Kitamura K, Yamamoto H, Asaumi Y, Ishibashi-Ueda H, Kishida M, Arisato T, Matsuo M, Miyazato M, Yasuda S (2021) Combined evaluation of plasma B-type natriuretic peptide and urinary liver-type fatty acid-binding protein/creatinine ratio is related to worsening renal function in patients undergoing elective percutaneous coronary intervention. Clin Exp Nephrol 25:1319–1328PubMedCrossRef
40.
go back to reference Peabody J, Paculdo D, Valdenor C, McCullough P, Noiri E, Sugaya T, Dahlen J (2022) Clinical utility of a biomarker to detect contrast-induced acute kidney injury during percutaneous cardiovascular procedures. Cardiorenal Med 12:11–19PubMedCrossRef Peabody J, Paculdo D, Valdenor C, McCullough P, Noiri E, Sugaya T, Dahlen J (2022) Clinical utility of a biomarker to detect contrast-induced acute kidney injury during percutaneous cardiovascular procedures. Cardiorenal Med 12:11–19PubMedCrossRef
41.
go back to reference Pan Q, Zhang W, Li X, Chen Z, Yang Y, Wang G (2022) Sex difference in the association between neutrophil to lymphocyte ratio and severity of coronary artery disease. Angiology 73:470–477PubMedCrossRef Pan Q, Zhang W, Li X, Chen Z, Yang Y, Wang G (2022) Sex difference in the association between neutrophil to lymphocyte ratio and severity of coronary artery disease. Angiology 73:470–477PubMedCrossRef
42.
go back to reference Agarwal R, Aurora R, Siswanto B, Muliawan H (2022) The prognostic value of neutrophil-to-lymphocyte ratio across all stages of coronary artery disease. Coron Artery Dis 33:137–143PubMedCrossRef Agarwal R, Aurora R, Siswanto B, Muliawan H (2022) The prognostic value of neutrophil-to-lymphocyte ratio across all stages of coronary artery disease. Coron Artery Dis 33:137–143PubMedCrossRef
43.
go back to reference Yilmaz Y, Kelesoglu S, Kalay N (2022) A novel predictor of contrast-induced nephropathy in patients with carotid artery disease; the systemic immune inflammation index. Angiology 73:781–787PubMedCrossRef Yilmaz Y, Kelesoglu S, Kalay N (2022) A novel predictor of contrast-induced nephropathy in patients with carotid artery disease; the systemic immune inflammation index. Angiology 73:781–787PubMedCrossRef
44.
go back to reference Öztürk R, İnan D, Güngör B (2022) Systemic immune-inflammation index is a predictor of contrast-induced nephropathy in patients with ST-segment elevation myocardial infarction. Angiology 73:125–131PubMedCrossRef Öztürk R, İnan D, Güngör B (2022) Systemic immune-inflammation index is a predictor of contrast-induced nephropathy in patients with ST-segment elevation myocardial infarction. Angiology 73:125–131PubMedCrossRef
45.
go back to reference Lin Q, Li S, Jiang N, Jin H, Shao X, Zhu X, Wu J, Zhang M, Zhang Z, Shen J, Zhou W, Gu L, Lu R, Ni Z (2021) Inhibiting NLRP3 inflammasome attenuates apoptosis in contrast-induced acute kidney injury through the upregulation of HIF1A and BNIP3-mediated mitophagy. Autophagy 17:2975–2990PubMedCrossRef Lin Q, Li S, Jiang N, Jin H, Shao X, Zhu X, Wu J, Zhang M, Zhang Z, Shen J, Zhou W, Gu L, Lu R, Ni Z (2021) Inhibiting NLRP3 inflammasome attenuates apoptosis in contrast-induced acute kidney injury through the upregulation of HIF1A and BNIP3-mediated mitophagy. Autophagy 17:2975–2990PubMedCrossRef
Metadata
Title
Biomarker array for prediction of acute kidney injury after percutaneous coronary intervention for patients who had acute ST segment elevation myocardial infarction
Authors
Amr Alkassas
Yasser Elbarbary
Mohammed H. Sherif
Shaimaa B. El-Saied
Rasha Y. Hagag
Mohammed Elbarbary
Publication date
13-11-2023
Publisher
Springer Japan
Published in
Heart and Vessels / Issue 3/2024
Print ISSN: 0910-8327
Electronic ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-023-02330-0

Other articles of this Issue 3/2024

Heart and Vessels 3/2024 Go to the issue